Various epidemiological scientific studies are already carried out about the incidence of breast, endometrial, ovarian and cervical cancer in Gals applying oral contraceptives. The potential risk of acquiring breast most cancers diagnosed could be a bit amplified between recent and up to date consumers of COCs. Nonetheless, this surplus possibility